Delorazepam

Delorazepam is a benzodiazepine derivative of desmethyldiazepam, primarily used in the treatment of anxiety disorders and alcohol withdrawal. It is marketed in Italy and is notable for its exceptionally long half-life of 60 to 140 hours. Delorazepam also serves as an active metabolite of both diclazepam and cloxazolam. Like other benzodiazepines, it possesses anxiolytic, muscle relaxant, hypnotic, and anticonvulsant properties, and carries a risk of dependence with repeated use.

Also known as: En, Dadumir, Nordiclazepam, Chlordesmethyldiazepam

Classification

Chemical: Benzodiazepine
Chemical: Medicine
Psychoactive: Depressant
Tag: Anxiolytic
Tag: GABAergic
Tag: Habit-Forming
Tag: Muscle Relaxant

Effects

Sedation
Muscle Relaxation
Respiratory Depression
Anxiolytic
Sedative
Dystaxia
Euphoria
Anxiety
Depression
Anxiety Suppression
Amnesia
Motor Control Loss
Hallucinations
Disinhibition
Dulled Perception

Routes of Administration

Oral

Dosage

Heavy: 2-3 mg
Light: 0.25 – 0.5 mg
Common: 0.5 – 1.5 mg
Strong: 1.5 – 2 mg
Threshold: 0.25 mg

Duration

Onset: 0.5-1 h
After Effects: 72 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu